ASCVD Risk Estimator Plus
ASO Keyword Dashboard
Tracking 75 keywords for ASCVD Risk Estimator Plus in Apple App Store
ASCVD Risk Estimator Plus tracks 75 keywords (no keywords rank yet; 75 need traction). Key metrics: opportunity 44.4, difficulty 36.8.
Tracked keywords
75
0 ranked • 75 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
44.4
Top keyword: best
Avg difficulty
36.8
Lower scores indicate easier wins
Opportunity leaders
- 85.9
best
Opportunity: 59.0 • Difficulty: 59.6 • Rank —
Competitors: 1,398
- 85.2
help
Opportunity: 59.0 • Difficulty: 61.1 • Rank —
Competitors: 1,236
- 73.9
change
Opportunity: 58.0 • Difficulty: 53.7 • Rank —
Competitors: 400
- 69.9
care
Opportunity: 58.0 • Difficulty: 49.2 • Rank —
Competitors: 262
- 77.7
support
Opportunity: 58.0 • Difficulty: 55.8 • Rank —
Competitors: 515
Unranked opportunities
best
Opportunity: 59.0 • Difficulty: 59.6 • Competitors: 1,398
help
Opportunity: 59.0 • Difficulty: 61.1 • Competitors: 1,236
change
Opportunity: 58.0 • Difficulty: 53.7 • Competitors: 400
care
Opportunity: 58.0 • Difficulty: 49.2 • Competitors: 262
support
Opportunity: 58.0 • Difficulty: 55.8 • Competitors: 515
High competition keywords
best
Total apps: 6,283 • Major competitors: 1,398
Latest rank: — • Difficulty: 59.6
help
Total apps: 5,873 • Major competitors: 1,236
Latest rank: — • Difficulty: 61.1
using
Total apps: 4,473 • Major competitors: 924
Latest rank: — • Difficulty: 61.4
based
Total apps: 3,039 • Major competitors: 697
Latest rank: — • Difficulty: 57.7
build
Total apps: 2,821 • Major competitors: 600
Latest rank: — • Difficulty: 55.4
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| best | 59 | 100 | 60 | 86 6,283 competing apps Median installs: 272,625 Avg rating: 4.6 | — | — | 1,398 major competitor apps |
| change | 58 | 100 | 54 | 74 1,855 competing apps Median installs: 267,450 Avg rating: 4.6 | — | — | 400 major competitor apps |
| care | 58 | 100 | 49 | 70 1,236 competing apps Median installs: 259,912 Avg rating: 4.6 | — | — | 262 major competitor apps |
| support | 58 | 100 | 56 | 78 2,741 competing apps Median installs: 233,950 Avg rating: 4.6 | — | — | 515 major competitor apps |
| date | 58 | 100 | 55 | 70 1,250 competing apps Median installs: 269,412 Avg rating: 4.7 | — | — | 274 major competitor apps |
| information | 58 | 100 | 57 | 78 2,704 competing apps Median installs: 252,888 Avg rating: 4.6 | — | — | 572 major competitor apps |
| management | 58 | 100 | 46 | 66 856 competing apps Median installs: 221,550 Avg rating: 4.6 | — | — | 138 major competitor apps |
| using | 58 | 100 | 61 | 83 4,473 competing apps Median installs: 247,200 Avg rating: 4.6 | — | — | 924 major competitor apps |
| help | 59 | 100 | 61 | 85 5,873 competing apps Median installs: 257,100 Avg rating: 4.6 | — | — | 1,236 major competitor apps |
| patients | 57 | 100 | 30 | 45 99 competing apps Median installs: 221,425 Avg rating: 4.6 | — | — | 21 major competitor apps |
| around | 58 | 100 | 60 | 78 2,784 competing apps Median installs: 275,088 Avg rating: 4.6 | — | — | 645 major competitor apps |
| patient | 57 | 100 | 30 | 45 94 competing apps Median installs: 207,600 Avg rating: 4.7 | — | — | 14 major competitor apps |
| tool | 58 | 100 | 47 | 69 1,134 competing apps Median installs: 210,275 Avg rating: 4.6 | — | — | 170 major competitor apps |
| plan | 58 | 100 | 55 | 73 1,690 competing apps Median installs: 264,238 Avg rating: 4.7 | — | — | 380 major competitor apps |
| plus | 20 | 100 | 53 | 67 947 competing apps Median installs: 342,375 Avg rating: 4.6 | — | — | 264 major competitor apps |
| type | 58 | 100 | 46 | 65 765 competing apps Median installs: 272,225 Avg rating: 4.6 | — | — | 166 major competitor apps |
| discussion | 56 | 100 | 35 | 35 34 competing apps Median installs: 192,038 Avg rating: 4.6 | — | — | 7 major competitor apps |
| year | 58 | 100 | 47 | 67 918 competing apps Median installs: 268,412 Avg rating: 4.6 | — | — | 195 major competitor apps |
| course | 57 | 100 | 40 | 57 329 competing apps Median installs: 245,150 Avg rating: 4.7 | — | — | 60 major competitor apps |
| user | 58 | 100 | 52 | 77 2,498 competing apps Median installs: 242,250 Avg rating: 4.6 | — | — | 453 major competitor apps |
| feedback | 58 | 100 | 48 | 66 871 competing apps Median installs: 261,525 Avg rating: 4.6 | — | — | 186 major competitor apps |
| decision | 57 | 100 | 33 | 49 152 competing apps Median installs: 197,275 Avg rating: 4.7 | — | — | 30 major competitor apps |
| assessment | 20 | 100 | 34 | 40 56 competing apps Median installs: 493,512 Avg rating: 4.6 | — | — | 18 major competitor apps |
| expert | 58 | 100 | 49 | 64 662 competing apps Median installs: 275,100 Avg rating: 4.7 | — | — | 159 major competitor apps |
| guideline | 0 | 34 | 10 | 16 4 competing apps Median installs: 205,288 Avg rating: 4.6 | — | — | 0 major competitor apps |
App Description
Use the app to:
• Estimate a patient’s initial 10-year ASCVD risk using the pooled cohort equation
• Receive an individualized, risk-based, intervention approach
• Project the impact of specific interventions on a patient’s risk
• Guide clinician-patient discussion around customizing an intervention plan
• Update risk at follow-up based on a patient’s response to therapy using the Million Hearts Longitudinal model
Advice from the app is derived from the 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes, the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, the 2018 ACC/AHA et al. Guideline on the Management of Blood Cholesterol, the 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment, the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk, and the 2016 Million Hearts Longitudinal ASCVD Risk Assessment Tool user guide.
The information and recommendations in this clinical decision support tool are meant to support clinical decision making. They are not meant to represent the only or best course of care or replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.